Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-16-019419
Filing Date
2016-12-14
Accepted
2016-12-14 17:11:25
Documents
1
Effectiveness Date
2016-12-14

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS defa14a1216_actinium.htm DEFA14A 13056
  Complete submission text file 0001213900-16-019419.txt   14153
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36374 | Film No.: 162051761
SIC: 2834 Pharmaceutical Preparations